ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.33
-0.75%
US Tech 100
17,336.80
-2.40%
S&P 500
5,158.20
-2.36%
US Dollar vs CAD
1.38336
-0.01%
Bitcoin
87,325.69
-0.21%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Trinity Biotech PLC (TRIB)

  7. Trinity Biotech PLC (TRIB) News

TRIB

Trinity Biotech (TRIB)

Trinity Biotech PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRIB
DateTimeSourceHeadlineSymbolCompany
04/04/20257:39AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
03/31/20257:33AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRIBTrinity Biotech PLC
03/30/202511:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TRIBTrinity Biotech PLC
03/25/20255:29PMEdgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
03/21/20254:00PMEdgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:TRIBTrinity Biotech PLC
03/14/20253:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
03/14/20253:30PMGlobeNewswire Inc.Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price RequirementNASDAQ:TRIBTrinity Biotech PLC
03/13/20256:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
03/13/20256:30AMGlobeNewswire Inc.Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment ProcessNASDAQ:TRIBTrinity Biotech PLC
02/28/20257:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
02/28/20257:30AMGlobeNewswire Inc.Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company’s Continuous Glucose Monitoring TechnologyNASDAQ:TRIBTrinity Biotech PLC
02/14/20253:15PMEdgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
02/06/20258:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
02/06/20256:30AMGlobeNewswire Inc.Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal TrialNASDAQ:TRIBTrinity Biotech PLC
02/04/20257:36AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
01/29/20254:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
01/28/202510:33AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
01/28/20256:20AMGlobeNewswire Inc.Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) TechnologyNASDAQ:TRIBTrinity Biotech PLC
12/27/20243:14PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
12/27/20243:05PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRIBTrinity Biotech PLC
12/26/20245:19PMEdgar (US Regulatory)Form SCHEDULE 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:TRIBTrinity Biotech PLC
12/24/20247:33AMGlobeNewswire Inc.Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation PlanNASDAQ:TRIBTrinity Biotech PLC
12/19/20248:55PMEdgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
12/18/202411:02AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
12/18/202410:00AMGlobeNewswire Inc.Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIVNASDAQ:TRIBTrinity Biotech PLC
12/17/20243:56PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
12/17/20243:42PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRIBTrinity Biotech PLC
12/05/20243:30PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRIBTrinity Biotech PLC
12/02/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TRIBTrinity Biotech PLC
11/29/20243:45PMEdgar (US Regulatory)Form F-3/A - Registration statement by foreign private issuers: [Amend]NASDAQ:TRIBTrinity Biotech PLC
 Showing the most relevant articles for your search:NASDAQ:TRIB

Your Recent History

BIT
UC8C70
Unicredit Bank
BIT
P1OT45
BNP Paribas Issuance
BIT
UC6M1H
Unicredit Bank
BIT
P1P0O5
BNP Paribas Issuance
BIT
UC6GMW
Unicredit Bank
NYSE
GRBK
Green Brick Partners
BIT
UB8PEG
Unicredit Bank
BIT
UC4VD5
Unicredit Bank
NASDAQ
FLD
Fold
AMEX
EZM
WisdomTree US MidCap
BIT
UB7DK7
Unicredit Bank
USOTC
VICP
Vicapsys Life Sciences (CE)
BIT
UC8HRR
Unicredit Bank
TSXV
BMV.H
Bathhurst Metals
BIT
UC3F9A
Unicredit Bank
BIT
UB4QEH
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads